Insights from recent episode analysis
Audience Interest
Estimated Reach: 10,001 - 20,000
Listeners across platforms
Podcast Focus
Categories: science · life
Publishing Consistency
Frequency: Irregular
250+ episodes since 2020
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
drug developmentbiotechnologycell and gene therapyleadershipoperationssupply chain
Brands & references
Genezen1
Brammer Bio1
Thermo Fisher1
Ampersand Capital Partners1
Generic platforms filtered out.
High Confidence
Est. Listeners
10,001 - 20,000
Based on iTunes & Spotify (publisher stats).
- Per-Episode Audience
Est. listeners per new episode within ~30 days
25,001 - 50,000 - Monthly Reach
Unique listeners across all episodes (30 days)
25,001 - 75,000 - Active Followers
Loyal subscribers who consistently listen
15,001 - 40,000
Market Insights
This ShowCategory Avg
No category insights available.
📡
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 1 epsHost
RS
Raman Sehgal
1 ep
Recent guests
SF
Steve Favaloro
1 ep
Recent episodes
The Making of a CGT CDMO Builder
May 1, 2026
58m 19s
🔗
Social Links & Contact
Official channels & resources
🌐
Official Website
Login
📡
RSS Feed
Login
Episodes
1
Avg length
58m 19s
Range
Sep 2020 – Apr 2026
Topics
6
drug development, biotechnology +4
Guests
1
Steve Favaloro · last 1 eps
1 of 1
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 5/1/26 | The Making of a CGT CDMO Builder✨ | drug developmentbiotechnology+4 | Steve Favaloro | GenezenBrammer Bio+2 | — | CGT CDMObiotech executive+4 | — | 58m 19s |
Showing 1 of 1
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
Chart Positions
13 placements across 12 markets.
Chart Positions
13 placements across 12 markets.